Monday, December 23, 2024
HomeTagsBecker Hewes

Becker Hewes

Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT

Blueprint Medicines Corporation announced the submission of a supplemental new drug application to the U.S. Food and Drug Administration (FDA) for AYVAKIT® (avapritinib) for...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics